This role for ARNO may offer new options for modulating synovial fibroblast-mediated inflammation, cartilage and bone damage in chronic inflammatory joint diseases, such as RA, without severely compromising systemic immune responses. This evidence concerns the gene CYTH2 and rheumatoid arthritis.